Do patients need heart testing before starting Cosentyx (secukinumab)?
Based on the information available in the provided sources, Cosentyx (secukinumab) is not specifically described as requiring dedicated cardiovascular screening (such as ECGs, echocardiograms, stress tests, or coronary imaging) before starting treatment. Instead, pre-treatment evaluation focuses on standard safety screening for biologic therapy and on infection risk (for example, checking for tuberculosis and other active infections, as clinically appropriate) rather than routine cardiovascular workups.
What pre-start screening is usually checked for biologics like Cosentyx?
For biologics, clinicians commonly review:
- Infection status (including tuberculosis screening and ruling out active infection)
- Baseline clinical history relevant to treatment safety (for example, current infections, immunosuppression risks, and other comorbidities)
The provided information does not call out additional cardiovascular-specific screening requirements before Cosentyx initiation.
When might cardiovascular evaluation still be needed before or during treatment?
Even if routine cardiovascular screening is not required specifically because of Cosentyx, a clinician may still order cardiovascular testing if a patient has:
- Known cardiovascular disease (for example, established heart failure, coronary artery disease, prior arrhythmias)
- New or worsening cardiovascular symptoms before starting therapy (such as chest pain, syncope, unexplained shortness of breath, palpitations)
- Uncontrolled cardiovascular risk factors that require medical optimization regardless of biologic choice
In those cases, the cardiovascular workup would be driven by symptoms and existing disease risk, not by a mandated Cosentyx pre-screening protocol.
Is there any Cosentyx cardiovascular “alert” that changes screening?
The provided sources do not describe a specific cardiovascular “alert” that would change pre-treatment screening requirements for Cosentyx beyond standard medical evaluation.
---
If you share the reason you’re considering Cosentyx (psoriasis, psoriatic arthritis, ankylosing spondylitis, etc.) and the patient’s age plus any known heart conditions or symptoms, I can map those details to the types of baseline checks doctors typically do in practice.